Bioventus, Inc. (BVS)
8.97
-0.18
(-1.97%)
USD |
NASDAQ |
Apr 02, 16:00
8.955
-0.02
(-0.17%)
After-Hours: 20:00
Bioventus Shareholders Equity (Quarterly) : 184.10M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 52.13B |
| Accuray, Inc. | 53.42M |
| Alphatec Holdings, Inc. | 36.03M |
| Boston Scientific Corp. | 24.23B |
| Plus Therapeutics, Inc. | 3.996M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 683.56M |
| Total Liabilities (Quarterly) | 455.11M |
| Debt to Equity Ratio | 1.691 |
| Current Ratio | 1.701 |
| Net Debt Paydown Yield | 3.33% |